IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils

Journal of Cutaneous Pathology

Volumn 35, Issue SUPPL. 1, 2008, Pages 38-45

  Slone, Stephen P ^a   Martin, Alvin W ^a   Wellhausen, Samuel R ^a   Woods, Dustin R ^a   Malone, Janine C ^a   Lear, Sheron C ^a   Laber, Damian A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CLUSTERIN; INTERLEUKIN 4;

AGED; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DERMIS; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; PAPULE; PUNCH BIOPSY; SKIN BIOPSY; SKIN NECROSIS; SKIN ULCER;

AGED; ANTIGENS, CD; BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; LYMPHOCYTE SUBSETS; LYMPHOMATOID PAPULOSIS; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS;

EID: 50849118199     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00973.x     Document Type: Article

References (38)

1. Macaulay WL. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 1968 97 : 23.
2. Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 1985 119 : 315.
3. Ralfkiaer E, Stein H, Wantzin GL, Thomsen K, Ralfkiaer N, Mason DY. Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies. Am J Clin Pathol 1985 84 : 587.
4. Ralfkiaer E, Delsol G, Willemze R, Jaffe ES. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In Jaffee ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press, 2001 221.
5. Weiss LM, Wood GS, Trela M, Warnke RA, Sklar J. Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986 315 : 475.
6. Kadin ME, Vonderheid EC, Sako D, Clayton LK, Olbricht S. Clonal composition of T cells in lymphomatoid papulosis. Am J Pathol 1987 126 : 13.
7. Whittaker S, Smith N, Jones RR, Luzzatto L. Analysis of ß, γ and δ T-cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 1991 96 : 786.
8. Gallardo F, Costa C, Bellosillo B, et al. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases. Acta Derm Venereol (Norway) 2004 84 : 463.
9. Zackheim HS, Jones C, Leboit PE, Kashani-Sabet M, McCalmont TH, Zehnder J. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol 2003 49 : 620.
10. Gellrich S, Wernicke M, Wilks A, et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). J Invest Dermatol 2004 122 : 859.
11. Willemze R, Meijer CJLM. Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC. J Cutan Pathol 2006 33 : 18.
12. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997 90 : 354.
13. Hellman J, Phelps RG, Baral J, Fasy TM, Ahern CM, Strauchen JA. Lymphomatoid papulosis with antigen deletion and clonal rearrangement in a 4-year-old boy. Pediatr Dermatol 1990 7 : 42.
14. Berti E, Tomasini D, Vermeer MH, Meijer CJLM, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. Am J Pathol 1999 155 : 483.
15. Aoki E, Aoki M, Kono M, Kawana S. Two cases of lymphomatoid papulosis in children. Pediatr Dermatol 2003 20 : 146.
16. Wu W-M, Tsai H-J. Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma. A case report. Am J Dermatopathol 2004 26 : 133.
17. El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis. Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004 140 : 441.
18. Magro CM, Crowson AN, Morrison C, Merati K, Porcu P, Wright ED. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol 2006 125 : 490.
19. Flann S, Orehard GE, Wain EM, Russell-Jones R. Three cases of lymphomatoid papulosis with a CD56+ immunophenotype. J Am Acad Dermatol 2006 55 : 903.
20. Seder RA, Mosmann TM. Differentiation of effector phenotypes of CD4+ and CD8+ T cells. In Paul WE, ed. Fundamental immunology. Philadelphia : Lippincott-Raven, 1999 : 879.
21. Delfs MW, Furukawa Y, Mitchell RN, Lichtman AH. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 2001 71 : 606.
22. Gordon S. Macrophages and the immune response. In Paul WE, ed. Fundamental immunology. Philadelphia : Lippincott-Raven 1999 : 533 545.
23. Schnickel GT, Whiting D, Hsieh GR, et al. CD8 lymphocytes are sufficient for the development of chronic rejection. Transplantation 2004 78 : 1634.
24. Fischbein MP, Yun J, Laks H, et al. Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2002 123 : 803.
25. Fischbein MP, Yun J, Laks H, et al. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model. Transplantation 2001 71 : 1146.
26. Galli SJ, Lantz CS. Allergy. In Paul WE, ed. Fundamental immunology. Philadelphia : Lippincott-Raven, 1999 1127.
27. Burg G, Kempf W, Smoller B, et al. Mycosis fungoides. In LeBoit PE, Burg G, Weedon D, Sarasin A, eds. World Health Organization classification of tumours. Pathology and genetics. Skin tumours. Lyon : IARC Press, 2006 169.
28. Fujiwara Y, Abe Y, Kuyama M, et al. CD8+ cutaneous T-cell lymphoma with pagetoid epidermotropism and angiocentric and angiodestructive infiltration. Arch Dermatol 1990 126 : 801.
29. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003 101 : 3407.
30. David M, Ford D, Bertoglio J, Maizel AL, Pierre J. Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 2001 20 : 6660.
31. Cancino-Diaz JC, Reyes-Maldonado E, Banuelos-Panuco CA, et al. Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. J Invest Dermatol 2002 119 : 1114.
32. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993 28 : 973.
33. Kadin ME. The spectrum of Ki-1+ cutaneous lymphomas. Curr Probl Dermatol 1990 19 : 132 143.
34. Ralfkiaer E, Willemze R, Meijer CJLM, et al. Primary cutaneous peripheral T-cell lymphoma, unspecified. In LeBoit PE, Burg G, Weedon D, Sarasin A, eds. World Health Organization classification of tumours. Pathology and genetics. Skin tumours. Lyon : IARC Press, 2006 184.
35. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004 28 : 719.
36. Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol 2006 33 : 10.
37. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001 182 : 68.
38. Bekkenk MW, Geelen FA, Voorst Vader PC, et al. guidelines Primary and secondary cutaneous CD30 (+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and for diagnosis and treatment. Blood 2000 95 : 3653.